Literature DB >> 32016100

Does diabetes mellitus play an independent prognostic role in kidney cancer?

Johannes Breyer1.   

Abstract

Entities:  

Year:  2019        PMID： 32016100      PMCID： PMC6976440          DOI： 10.21037/atm.2019.12.85

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  16 in total

1.  Diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis.

Authors:  Cuiping Bao; Xilin Yang; Weili Xu; Hongbin Luo; Zhongliang Xu; Cheng Su; Xiuying Qi
Journal:  J Diabetes Complications       Date:  2013-02-20       Impact factor: 2.852

2.  [Clinical and pathological prognostic factors for the long-term survival of patients with pT1 renal cell carcinoma].

Authors:  Johannes Breyer; Wolfgang Otto; Eva Maria Lausenmeyer; Stefan Denzinger; Ann-Kathrin Schwientek; Ludwig Ochs; Roman Mayr; Michael Gierth; Johannes Bründl; Maximilian Burger; Matthias Evert; Hans-Martin Fritsche; Christian Eichelberg
Journal:  Aktuelle Urol       Date:  2017-04-19       Impact factor: 0.658

3.  Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft.

Authors:  Jun Liu; Ming Li; Bo Song; Chunhong Jia; Lichao Zhang; Xiaochun Bai; Weilie Hu
Journal:  Urol Oncol       Date:  2011-06-15       Impact factor: 3.498

Review 4.  Epidemiology and risk factors for kidney cancer.

Authors:  Wong-Ho Chow; Linda M Dong; Susan S Devesa
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

5.  Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.

Authors:  Madhur Nayan; Shreya Jalali; Anil Kapoor; Antonio Finelli; Alan So; Ricardo Rendon; Rodney H Breau; Luke T Lavallee; Simon Tanguay; Daniel Heng; Jun Kawakami; Naveen S Basappa; Georg Bjarnason; Frederic Pouliot; Robert J Hamilton
Journal:  Urol Oncol       Date:  2019-07-05       Impact factor: 3.498

6.  Diabetes and kidney cancer outcomes: a propensity score analysis.

Authors:  Madhur Nayan; Antonio Finelli; Michael A S Jewett; David N Juurlink; Peter C Austin; Girish S Kulkarni; Robert J Hamilton
Journal:  Endocrine       Date:  2016-11-04       Impact factor: 3.633

7.  Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.

Authors:  Lana Hamieh; Rana R McKay; Xun Lin; Raphael B Moreira; Ronit Simantov; Toni K Choueiri
Journal:  Clin Genitourin Cancer       Date:  2016-06-29       Impact factor: 2.872

8.  Contemporary epidemiology of renal cell cancer.

Authors:  Wong-Ho Chow; Susan S Devesa
Journal:  Cancer J       Date:  2008 Sep-Oct       Impact factor: 3.360

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

10.  Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma.

Authors:  Daniel Keizman; Maya Ish-Shalom; Avishay Sella; Maya Gottfried; Natalie Maimon; Avivit Peer; Hans Hammers; Mario A Eisenberger; Victoria Sinibaldi; Victoria Neiman; Eli Rosenbaum; David Sarid; Wilmosh Mermershtain; Keren Rouvinov; Raanan Berger; Michael A Carducci
Journal:  Clin Genitourin Cancer       Date:  2016-04-27       Impact factor: 2.872
View more
  2 in total

1.  Association between type 2 diabetes and cancer incidence in China: data in hospitalized patients from 2006 to 2013.

Authors:  Shan Lu; Anzhi Wang; Shumei Miao; Xin Zhang; Shenqi Jing; Tao Shan; Yongan Guo; Yun Liu
Journal:  Ann Transl Med       Date:  2020-03

2.  Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study.

Authors:  Huang-He He; Jun-Hui Fu; Zhe-Xue Hao; He-Fang Wu; Qiang Zhong; Fan Wang; Hang-Hui Liu; Xiang-Sen Gu; Bin Wang; Hao-Da Huang; Zhuo-Yi Li; Jian-Xing He
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.